Company profile
Hydrogen Hybrid Technologies, Inc.
OTC: HYHY · Healthcare · Medical - Pharmaceuticals
Canadian filerHQ Pickering, ONReports USD
#975 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ market scale, return on equity
Methodology →Revenue TTM
$287.7k
Rev growth YoY (TTM)
+16.1%
Net income (FY)
-$3.2M
Employees
—
as of 2026-08-30
Market cap
$2.8k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$291.2k$291.2k2008
Net income-$3.2M-$3.2M2008
Operating income-$3.1M-$3.1M2008
Total assets$2.3M$2.3M2008
Liabilities$1.4M$1.4M2008
Equity$912.7k$912.7k2008
Revenue trend
FY2005 – FY2008 · USD
FY05
FY06
FY07
FY08
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Hydrogen Hybrid Technologies, Inc.’s revenue?
Hydrogen Hybrid Technologies, Inc. booked $291.2k in FY2008 revenue, growing 141% year over year — faster than most Healthcare companies we track, at a -1085.2% net margin.
Peers · Healthcare
Tempest Therapeutics, Inc.24DMotus GI Holdings, Inc.——CannAmerica Brands Corp.——Aion Therapeutic Inc.——Abattis Bioceuticals Corp.——Entia Biosciences, Inc.——Key facts
CEOJan van Eck
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersPickering, ON
ExchangeOTC: HYHY
Employees—
IPO date2006-07-20
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.